CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.

X F Yang; C J Wu; S McLaughlin; A Chillemi; K S Wang; C Canning; E P Alyea; P Kantoff; R J Soiffer; G Dranoff

doi:10.1073/pnas.131590998

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.

Identifier:nobleid.org/w1/20260515/79D846DF

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/79D846DF.svg?ark=w1%2F20260515%2F79D846DF)](https://nobleid.org/work/w1/20260515/79D846DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.

Identifier:nobleid.org/w1/20260515/79D846DF

Type:Conference Paper

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/79D846DF.svg?ark=w1%2F20260515%2F79D846DF)](https://nobleid.org/work/w1/20260515/79D846DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work